Javascript must be enabled to continue!
Genome Editing in Caenorhabditis briggsae using the CRISPR/Cas9 System
View through CrossRef
Author Summary
The CRISPR/Cas9 system has recently emerged as a powerful tool to engineer the genome of an organism. The system is adopted from bacteria where it confers immunity against invading foreign DNA. This work reports the first successful use of the CRISPR/Cas9 system in
C. briggsae
, a cousin of the well-known nematode
C. elegans
. We used two plasmids, one expressing Cas9 endonuclease and the other an engineered CRISPR RNA corresponding to the DNA sequence to be cleaved. Our approach allows for the generation of loss-of-function mutations in
C. briggsae
genes thereby facilitating a comparative study of gene function between nematodes.
Abstract
The CRISPR/Cas9 system is an efficient technique for generating targeted alterations in an organism’s genome. Here we describe a methodology for using the CRISPR/Cas9 system to generate mutations via non-homologous end joining in the nematode
Caenorhabditis briggsae,
a sister species of
C. elegans
. Evidence for somatic mutations and off-target mutations are also reported. The use of the CRISPR/Cas9 system in
C. briggsae
will greatly facilitate comparative studies to
C. elegans.
Title: Genome Editing in
Caenorhabditis briggsae
using the CRISPR/Cas9 System
Description:
Author Summary
The CRISPR/Cas9 system has recently emerged as a powerful tool to engineer the genome of an organism.
The system is adopted from bacteria where it confers immunity against invading foreign DNA.
This work reports the first successful use of the CRISPR/Cas9 system in
C.
briggsae
, a cousin of the well-known nematode
C.
elegans
.
We used two plasmids, one expressing Cas9 endonuclease and the other an engineered CRISPR RNA corresponding to the DNA sequence to be cleaved.
Our approach allows for the generation of loss-of-function mutations in
C.
briggsae
genes thereby facilitating a comparative study of gene function between nematodes.
Abstract
The CRISPR/Cas9 system is an efficient technique for generating targeted alterations in an organism’s genome.
Here we describe a methodology for using the CRISPR/Cas9 system to generate mutations via non-homologous end joining in the nematode
Caenorhabditis briggsae,
a sister species of
C.
elegans
.
Evidence for somatic mutations and off-target mutations are also reported.
The use of the CRISPR/Cas9 system in
C.
briggsae
will greatly facilitate comparative studies to
C.
elegans.
Related Results
Introduction to CRISPR/Cas9
Introduction to CRISPR/Cas9
Clustered Regularly Interspersed Short Palindromic Repeats (often referred to as CRISPR) is a revolutionary new genome engineering technology that is capable of modifying virtually...
Genome engineering using CRISPR
Genome engineering using CRISPR
Clustered Regularly Interspersed Short Palindromic Repeats (often referred to as CRISPR) is a revolutionary new genome engineering technology that is capable of modifying virtually...
Diverse evolutionary roots and mechanistic variations of the CRISPR-Cas systems
Diverse evolutionary roots and mechanistic variations of the CRISPR-Cas systems
BACKGROUND
Prokaryotes have evolved multiple systems to combat invaders such as viruses and plasmids. Examples of such defense systems include receptor masking,...
Chromosome-level reference genomes for two strains of Caenorhabditis briggsae: an improved platform for comparative genomics
Chromosome-level reference genomes for two strains of Caenorhabditis briggsae: an improved platform for comparative genomics
AbstractThe publication of the Caenorhabditis briggsae reference genome in 2003 enabled the first comparative genomics studies between C. elegans and C. briggsae, shedding light on...
EVALUATION OF CRISPR/CAS9 GENOME-EDITING SYSTEM IN HUMAN STEM CELLS HSCS: THERAPEUTICS AND DIAGNOSTICS PROSPECTS
EVALUATION OF CRISPR/CAS9 GENOME-EDITING SYSTEM IN HUMAN STEM CELLS HSCS: THERAPEUTICS AND DIAGNOSTICS PROSPECTS
Background: CRISPR/Cas9 genome-editing technology has revolutionized human stem cell (HSC) research, offering novel therapeutic and diagnostic applications. HSCs play a crucial rol...
CRISPR/Cas9 genome editing clinical trials for neurodevelopmental disorders
CRISPR/Cas9 genome editing clinical trials for neurodevelopmental disorders
IntroductionRecently, the new therapeutic approach based on genome editing using the CRISPR/Cas9 system has been applied to treat cancer and other monogenetic disorders. CRISPR/Cas...
A viral guide RNA delivery system for CRISPR-based transcriptional activation and heritable targeted DNA demethylation in
Arabidopsis thaliana
A viral guide RNA delivery system for CRISPR-based transcriptional activation and heritable targeted DNA demethylation in
Arabidopsis thaliana
Abstract
Plant RNA viruses are used as delivery vectors for their high level of accumulation and efficient spread during virus multiplication and...
CRISPR-Cas9 in gene therapy: much control on breaking, little control on repairing
CRISPR-Cas9 in gene therapy: much control on breaking, little control on repairing
Recent advances in CRISPR-Cas9 genome editing tool have made great promises to basic and biomedical research as well as gene therapy. Efforts to make the CRISPR-Cas9 system applica...

